BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 3006201)

  • 1. [Use of serological markers in the diagnosis and prognosis of chronic viral hepatitis].
    Valdovinos Díaz MA; Páez Rodríguez O; Galván Guerra E; Wolpert E
    Rev Invest Clin; 1985; 37(4):373-83. PubMed ID: 3006201
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis C virus and hepatocellular carcinoma].
    Habscheid W
    Dtsch Med Wochenschr; 1990 May; 115(19):758-9. PubMed ID: 2159872
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis.
    Kiyosawa K; Akahane Y; Nagata A; Furuta S
    Am J Gastroenterol; 1984 Oct; 79(10):777-81. PubMed ID: 6091443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New aspects in diagnosis and therapy of viral hepatitis].
    Altorfer J
    Internist (Berl); 1992 Sep; 33(9):602-9. PubMed ID: 1399393
    [No Abstract]   [Full Text] [Related]  

  • 5. IgM anti-HD in acute hepatitis D: diagnostic and prognostic significance.
    Aragona M; Macagno S; Caredda F; Crivelli O; Lavarini C; Bertolusso L; Farci P; Rizzetto M
    Prog Clin Biol Res; 1987; 234():243-8. PubMed ID: 3628379
    [No Abstract]   [Full Text] [Related]  

  • 6. Delta agent and hepatocellular carcinoma.
    Craxì A; Raimondo G; Giannuoli G; Longo G; Caltagirone M; Aragona M; Squadrito G; Pagliaro L
    Prog Clin Biol Res; 1983; 143():231-4. PubMed ID: 6322197
    [No Abstract]   [Full Text] [Related]  

  • 7. [The epidemiological aspects of chronic viral diseases of the liver].
    Ogarkov PI
    Voen Med Zh; 1995 Jul; (7):36-45, 80. PubMed ID: 7571510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concerning particularly delta agent infection, chronic hepatitis, and relation of hepatitis B infection to hepato-cellular carcinoma.
    Popper H
    Prog Clin Biol Res; 1983; 143():397-410. PubMed ID: 6322201
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular pathophysiology of persistent hepatitis B virus infection in relation to chronic liver disease and primary hepatocellular carcinoma.
    Shafritz DA; Hadziyannis SJ
    Monogr Pathol; 1987; (28):136-52. PubMed ID: 3023975
    [No Abstract]   [Full Text] [Related]  

  • 11. [Etiology of chronic diffuse liver damages].
    Nikushkina IN; Maev IV; Samsonov AA; Andreev NG; Salova LM
    Eksp Klin Gastroenterol; 2007; (5):36-9, 164. PubMed ID: 18389595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infection by delta agent in drug addicts].
    Buti M; Esteban R; Rodrigo JM; Rodrigo L; Jardi R; Guardia J
    Med Clin (Barc); 1985 May; 84(18):727-9. PubMed ID: 4021592
    [No Abstract]   [Full Text] [Related]  

  • 13. Budd-Chiari syndrome complicated by hepatocellular carcinoma with no evidence of infection with hepatitis virus: a case report.
    Kawaguchi T; Sata M; Ono N; Sakisaka S; Koga H; Ijuin H; Mitsuyama K; Ueno T; Kage M; Tanikawa K
    Hepatogastroenterology; 1999; 46(30):3237-40. PubMed ID: 10626193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the hypercarcinogenic state in chronic hepatitis: a clue to the prevention of human hepatocellular carcinoma.
    Hino O; Kajino K; Umeda T; Arakawa Y
    J Gastroenterol; 2002; 37(11):883-7. PubMed ID: 12483242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis.
    Kuper H; Ye W; Broomé U; Romelsjö A; Mucci LA; Ekbom A; Adami HO; Trichopoulos D; Nyrén O
    Hepatology; 2001 Oct; 34(4 Pt 1):714-8. PubMed ID: 11584367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishing a serologic detection procedure for non-A, non-B viral hepatitis].
    Stremmel W
    Z Gastroenterol; 1989 Dec; 27(12):743-5. PubMed ID: 2483286
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serological markers in viral hepatitis].
    Lisker Melman M
    Rev Invest Clin; 1990 Jul; 42 Suppl():3-8. PubMed ID: 19256125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in viral hepatitis.
    Foster GR
    Clin Med (Lond); 2009 Dec; 9(6):613-6. PubMed ID: 20095313
    [No Abstract]   [Full Text] [Related]  

  • 19. Viral hepatitis guide for practicing physicians. Cleveland Clinic of Medicine.
    Younossi ZM
    Cleve Clin J Med; 2000; 67 Suppl 1():SI6-45. PubMed ID: 11068358
    [No Abstract]   [Full Text] [Related]  

  • 20. [New knowledge of the therapy and prevention of liver diseases. Key points: hepatitis vaccinations--differential diagnosis of hepatitis].
    Eisenburg J
    Fortschr Med; 1985 Jan; 103(1-2):15-9. PubMed ID: 2982708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.